Details for New Drug Application (NDA): 050726
✉ Email this page to a colleague
NDA 050726 describes AUGMENTIN '400', which is a drug marketed by Us Antibiotics and is included in two NDAs. It is available from one supplier. Additional details are available on the AUGMENTIN '400' profile page.
The generic ingredient in AUGMENTIN '400' is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
The generic ingredient in AUGMENTIN '400' is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
Summary for 050726
| Tradename: | AUGMENTIN '400' |
| Applicant: | Us Antibiotics |
| Ingredient: | amoxicillin; clavulanate potassium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 200MG;EQ 28.5MG BASE | ||||
| Approval Date: | May 31, 1996 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 400MG;EQ 57MG BASE | ||||
| Approval Date: | May 31, 1996 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
